Results 91 to 100 of about 4,769 (183)

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma

open access: yesnpj Precision Oncology
Understanding the impact of tertiary lymphoid structures (TLSs) on acral melanoma (AM) and the tumor microenvironment (TME) is critical. We analyzed TLS features in primary AM lesions from 46 patients and identified intratumoral TLSs (intra-TLSs) in 25 ...
Xinyu Su   +5 more
doaj   +1 more source

Past failures and new horizons: the nuances of tertiary lymphoid structures in high-grade serous ovarian cancer may contribute to immunotherapy effectiveness

open access: yesJournal for ImmunoTherapy of Cancer
Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates that allow for optimal B-T cell crosstalk in solid tumors. Further, TLS are found in many solid tumors and are associated with improved patient survival and superior immunotherapeutic ...
Tullia C Bruno   +3 more
doaj   +1 more source

Tertiary lymphoid structures in colorectal cancer

open access: yesAnnals of Medicine
Background Tertiary lymphoid structures (TLS) are ectopic clusters of immune cells found in non-lymphoid tissues, particularly within the tumor microenvironment (TME).
Jianyu Lv   +5 more
doaj   +1 more source

606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy

open access: yesRegular and Young Investigator Award Abstracts, 2023
Robert Johnston   +19 more
openaire   +2 more sources

Identification of a tertiary lymphoid structure (TLS)-related signature for ovarian cancer prognosis suggests a potential role of STAT5A in TLS maturation

open access: yesGenes & Diseases
Jiani Yang   +9 more
openaire   +3 more sources

Non-immune regulation of tertiary lymphoid structures in cancer. [PDF]

open access: yesFront Immunol
Challen OK   +10 more
europepmc   +1 more source

IMpower110: tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first line atezolizumab ro chemotherapy

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Srivastava, Minu   +18 more
openaire   +1 more source

Home - About - Disclaimer - Privacy